Home | Contact Us

Hyperbaric Oxygen Therapy has been recognised to be effective in the treatment of  11 major medical conditions.  These conditions are approved by the international body governing the legitimate use of Hyperbaric Medicine; The Undersea and Hyperbaric Medical Society, UHMS.
The evidence seems to show that, when applied early and in an appropriate manner, the use of Hyperbaric Oxygen Therapy in the treatment of these conditions is associated with significantly improved outcomes. 
The conditions are: 
  • Decompression Illness and Arterial Gas Embolism
  • Necrotizing Soft Tissue Infection
  • Delayed Radiation Injury to soft tissue and bone
  • Selected Problem Wounds
  • Clostridial Myositis and Myonecrosis
  • Carbon monoxide poisoning
  • Crush injury and other Acute Traumatic Ischaemias
  • Intracranial Abscess
  • Compromised Skin Grafts and Flaps
  • Refractory Osteomyelitis
  • Thermal Burns
In certain instances the use of HBOT has been associated with both improved healing rates and decreased rates of major surgeries such as amputations. 
Intercranial abscess mortality rates dropped from 20% to 2% of patients treated with HBOT and amputations due to diabetic causes have been reduced by up to 50% where HBOT has been utilised in these cases.
Thousands of patients are treated successfully in Australia each year and it is estimated that tens of thousands are successfully treated world-wide.
However, the Australasian Hyperbaric & Dive Medicine Research Trust believes that HBOT is under-utilised and under-funded and that many more people would benefit by wider understanding and use of HBOT.
Our goal is to help correct this situation by acting as a funding source for new, Level One hyperbaric research.

Substantial funds have already been raised and the major part of these distributed as grants to two research projects.  Full information on these is in 'DETAILS OF ROUND ONE & ROUND TWO GRANT APPLICATIONS' in the main menu.
We envisage future research projects will encompass both clinical and mechanistic trials.
As these trials progress and the wider medical community is made aware of the benefits of HBOT, it is likely that:
  • The quality of life could be improved for thousands more people each year.
  • Professional medical time could be significantly reduced when treating certain conditions due to the faster healing.
  • Millions of dollars could be saved in medical and rehabilitation costs by using HBOT where proven appropriate.
Besides the accepted conditions, there are also several investigational areas that deserve more study: for example the use of HBO in strokes.
It would also be desirable if all of the UHMS-approved conditions including: Crush injuries, thermal burns, carbon monoxide poisoning and compromised skin grafts and flaps were fully covered by Medicare, and by all medical insurers, as the AHDMRT believe they should be.
To this end AHDMRT seeks the further support of the core groups of medical practitioners, practitioner groups and associations involved in hyperbaric medicine, and the medical industry itself to raise a further $200,000.  This money will be used partly to make on-going grants for specific projects but also to establish a major national and international fundraising campaign aimed at making upwards of $5 million a year available for this purpose.

Details of Proposed Avenues of Research can be found by clicking the menu button.
AHDMRT welcomes suggestions for research into other areas where HBOT may have a valid medical benefit.  We will consider input from medical professionals and others with a direct interest in hyperbaric medicine. Your contributions to any part of this endeavour will be gratefully received.

Areas of Specialty
    Site Map | Privacy Statement |
Copyright 2021    Australasian Hyperbaric & Diving Medicine Research Trust
   Website by Michael Vaney Marketing